Blue Whale Capital’s Idexx Laboratories IDXX Stock Holding History

Blue Whale Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-55,000	Closed	-$27.6M	–	17
2023 Q2	$27.6M	Buy	55,000 +5,750	+12%	+$2.76M	4.24%	9
2023 Q1	$24.6M	Sell	49,250 -38,750	-44%	-$18.5M	4.07%	10
2022 Q4	$35.9M	Buy	88,000 +22,500	+34%	+$8.73M	6.12%	10
2022 Q3	$21.3M	Sell	65,500 -9,000	-12%	-$3.31M	3.82%	12
2022 Q2	$26.1M	Sell	74,500 -35,000	-32%	-$14.3M	3.84%	11
2022 Q1	$59.9M	Buy	109,500 +48,500	+80%	+$25.5M	5.76%	9
2021 Q4	$40.2M	Buy	+61,000	New	+$38.3M	3.27%	14

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Blue Whale Capital's IDXX Position: Q3 2023 in Review

Blue Whale Capital sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 55,000 shares — an estimated $27.6M sold.

Blue Whale Capital first reported a position in IDXX in Q4 2021 and held it in 7 quarters. The position peaked at $59.9M in Q1 2022. 1,060 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

Blue Whale Capital reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
Blue Whale Capital sold 55,000 Idexx Laboratories shares in Q3 2023, an estimated $27.6M.
Blue Whale Capital first reported a position in Idexx Laboratories in Q4 2021 and held it in 7 quarters.
Blue Whale Capital's Idexx Laboratories position peaked at $59.9M in Q1 2022.
1,060 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Blue Whale Capital's 13F filing for Q3 2023, filed 13 Nov 2023.